BU

Bhutda Umang Rameshbhai

Active Director Director DIN 08206121
DIN 08206121 First appointment Aug 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2018
Shareholding value •••• Premium profile

About Bhutda Umang Rameshbhai

Data last updated:

Bhutda Umang Rameshbhai is a Director at Biothemis Private Limited (since 2018). The company operates in Pharma. Biothemis Private Limited reported revenue of ₹20.1 Lakh (FY 2025).

DIN 08206121
Primary Designation Director
Industry Pharma
First Appointment 24 Aug 2018
Oldest Company Age 8 yrs
Largest company Biothemis Private Limited · ₹20.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biothemis Private Limited U24239GJ2018PTC103713
Director24 Aug 20182018₹20.1 Lakh (FY 2025)Active

Board colleagues of Bhutda Umang Rameshbhai

Directorship timeline

Open interactive timeline →
Biothemis Private Limited
Premium access

Shareholding and investment profile for Bhutda Umang Rameshbhai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhutda Umang Rameshbhai

Bhutda Umang Rameshbhai currently holds 1 directorship: Biothemis Private Limited (Director, since 24 Aug 2018, revenue ₹20.1 Lakh (FY 2025)).

Bhutda Umang Rameshbhai was first appointed on 24 Aug 2018 as Director at Biothemis Private Limited.

The current boards of Bhutda Umang Rameshbhai's companies include Dushyant Ghanshyambhai Baroliya (Biothemis Private Limited), Meenu Devendra (Biothemis Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available